Biomanufacturing Industry News

1. GS1 Healthcare US Publishes New Guideline for Pharmaceutical Product Serialization, Traceability And Pedigree Implementation By 2015 3/12/2013

   The GS1 Healthcare US Secure Supply Chain Task Force, consisting of more than 50 members from throughout the supply chain, has developed a guideline to identify and serialize pharmaceutical products using GS1 identification numbers. The guideline titled “Applying GS1 Standards to U.S. Pharmaceutical Supply Chain Business Processes to Support Serialization, Pedigree and Track & Trace” enables pharmaceutical companies to trace the movement of products through the U.S. pharmaceutical supply chain.

2. Johnson & Johnson Announces Opening Of London Innovation Centre 3/12/2013

   Johnson & Johnson today announced the opening of the Johnson & Johnson Innovation centre in London, one of four regional hubs being established this year in the world's leading innovation hotspots.

3. New GSP Taking Effect Right After The 3rd Pharma Cold Chain China Event 3/6/2013

   Recently, the Ministry of Health issued the New GSP, which will be effective fromJune 1st, 2013. The improvement of the Pharmaceutical Cold Chain is one of the main goals.

4. Thomson Reuters Spotlights The Impact Of Personalized Medicine On Pharmaceutical R&D 12/14/2012

   The IP & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the publication of a new report that provides a comprehensive view of the potential effects of personalized medicine on drug research and development.

5. Cell Culture - Rising Demand For Biologics And Growing Visibility Of Approval Pathway For Biosimilars Will Create Growth Opportunities 11/19/2012

   GBI Research, the leading business intelligence provider, has released its latest research "Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities", which provides in-depth analysis on the processes, drivers and barriers of the cell culture market.

6. Sigma® Life Science Launches Novel, Affordable Pluripotent Stem Cell Culture Medium 10/15/2012

   Sigma-Aldrich® Corp. announced that Sigma Life Science, its innovative biological products and services research business, has launched Stemline® Pluripotent Culture Medium, a novel human pluripotent stem cell culture medium that provides a consistent environment for the long-term maintenance and growth of healthy pluripotent stem cells.

7. Insights On Regulatory, QbD And Formulation Of Nano Medicines At Nano Suspensions India 2012 7/19/2012

   CPhI introduces Nano Suspensions India 2012 which will be focusing on the most relevant and pressing issues around regulatory, QbD, solubility, stability and efficient scale-up of nano medicines.

8. ISPE And FDA Discuss Quality Standards At Joint CGMP Conference 6/11/2012

   ISPE just concluded its two-day CGMP Conference co-sponsored by the FDA (4-5 June 2012, Baltimore, MD) with resounding support from more than 300 participants to more aggressively advance the Society's role in facilitating discussions among industry and regulators on issues that strengthen the safety of pharmaceutical products and devices produced around the world.

9. SAGE® Labs Creates The First Tissue-Specific Gene Deletion In Rats 4/19/2012

   Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma® Life Science, extended CompoZr® Zinc Finger Nuclease (ZFN) technology to achieve the first tissue-specific conditional knockout of an endogenous gene in rats.

10. IQPC Presents The New Face Of Cold Chain IQ, The International Resource Centre For Temperature Control Professionals 4/17/2012

    ColdChainIQ.com the online network and content resource designed exclusively for the temperature control supply chain life science industry has relaunched with a brand new design and identity.